2,893
Views
19
CrossRef citations to date
0
Altmetric
Editorial

Binding modes of hERG blockers: an unsolved mystery in the drug design arena

&
Pages 207-210 | Received 07 Sep 2017, Accepted 13 Dec 2017, Published online: 18 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shiv Rakesh Naik, Prashant Bharadwaj, Nadia Dingelstad, Subha Kalyaanamoorthy, Subhash C Mandal, Aravindhan Ganesan, Debprasad Chattopadhyay & Partha Palit. (2022) Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 40:15, pages 6921-6938.
Read now
Shruti Koulgi, Vinod Jani, Vinay Nair, Jagmohan S. Saini, Samiron Phukan, Uddhavesh Sonavane, Rajendra Joshi, Raj Kamboj & Venkata Palle. (2022) Molecular dynamics of hERG channel: insights into understanding the binding of small molecules for detuning cardiotoxicity. Journal of Biomolecular Structure and Dynamics 40:13, pages 5996-6012.
Read now

Articles from other publishers (17)

Sara AlRawashdeh, Suryanarayanan Chandrasekaran & Khaled H. Barakat. (2023) Structural analysis of hERG channel blockers and the implications for drug design. Journal of Molecular Graphics and Modelling 120, pages 108405.
Crossref
Hongsong Feng & Guo-Wei Wei. (2023) Virtual screening of DrugBank database for hERG blockers using topological Laplacian-assisted AI models. Computers in Biology and Medicine 153, pages 106491.
Crossref
Michael C. Sanguinetti. 2023. Heart Rate and Rhythm. Heart Rate and Rhythm 255 274 .
Himanshu Goel, Wenbo Yu & Alexander D. MacKerellJr.Jr.. (2022) hERG Blockade Prediction by Combining Site Identification by Ligand Competitive Saturation and Physicochemical Properties. Chemistry 4:3, pages 630-646.
Crossref
Justine C Williams & Subha Kalyaanamoorthy. (2021) PoseFilter: a PyMOL plugin for filtering and analyzing small molecule docking in symmetric binding sites. Bioinformatics 37:19, pages 3367-3368.
Crossref
Kuo Hao Lee, Andrew D. Fant, Jiqing Guo, Andy Guan, Joslyn Jung, Mary Kudaibergenova, Williams E. Miranda, Therese Ku, Jianjing Cao, Soren Wacker, Henry J. Duff, Amy Hauck Newman, Sergei Y. Noskov & Lei Shi. (2021) Toward Reducing hERG Affinities for DAT Inhibitors with a Combined Machine Learning and Molecular Modeling Approach. Journal of Chemical Information and Modeling 61:9, pages 4266-4279.
Crossref
Teresa Maria Creanza, Pietro Delre, Nicola Ancona, Giovanni Lentini, Michele Saviano & Giuseppe Felice Mangiatordi. (2021) Structure-Based Prediction of hERG-Related Cardiotoxicity: A Benchmark Study. Journal of Chemical Information and Modeling 61:9, pages 4758-4770.
Crossref
Daniel Şterbuleac. (2021) Molecular dynamics: a powerful tool for studying the medicinal chemistry of ion channel modulators. RSC Medicinal Chemistry 12:9, pages 1503-1518.
Crossref
Simona Saponara, Fabio Fusi, Daniele Iovinelli, Amer Ahmed, Alfonso Trezza, Ottavia Spiga, Giampietro Sgaragli & Massimo Valoti. (2021) Flavonoids and hERG channels: Friends or foes?. European Journal of Pharmacology 899, pages 174030.
Crossref
Amy Hauck NewmanTherese KuChloe J. JordanAlessandro BonifaziZheng-Xiong Xi. (2021) New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders. Annual Review of Pharmacology and Toxicology 61:1, pages 609-628.
Crossref
N.S. Hari Narayana Moorthy, Chandrabose Karthikeyan & Elangovan Manivannan. (2021) Multi-algorithm based machine learning and structural pattern studies for hERG ion channel blockers mediated cardiotoxicity prediction. Chemometrics and Intelligent Laboratory Systems 208, pages 104213.
Crossref
Stefan Viktor Vormfelde, Nicole Pezous, Gilbert Lefèvre, Carine Kolly, Ulf Neumann, Pierre Jordaan, Mike Ufer & Eric Legangneux. (2020) A Pooled Analysis of Three Randomized Phase I/IIa Clinical Trials Confirms Absence of a Clinically Relevant Effect on the QTc Interval by Umibecestat. Clinical and Translational Science 13:6, pages 1316-1326.
Crossref
Subha Kalyaanamoorthy, Shawn M. Lamothe, Xiaoqing Hou, Tae Chul Moon, Harley T. Kurata, Michael Houghton & Khaled H. Barakat. (2020) A structure-based computational workflow to predict liability and binding modes of small molecules to hERG. Scientific Reports 10:1.
Crossref
Rachel D. Slack, Therese C. Ku, Jianjing Cao, JoLynn B. Giancola, Alessandro Bonifazi, Claus J. Loland, Alexandra Gadiano, Jenny Lam, Rana Rais, Barbara S. Slusher, Mark Coggiano, Gianluigi Tanda & Amy Hauck Newman. (2019) Structure–Activity Relationships for a Series of (Bis(4-fluorophenyl)methyl)sulfinyl Alkyl Alicyclic Amines at the Dopamine Transporter: Functionalizing the Terminal Nitrogen Affects Affinity, Selectivity, and Metabolic Stability. Journal of Medicinal Chemistry 63:5, pages 2343-2357.
Crossref
Andrew J. Wedlake, Maria Folia, Sam Piechota, Timothy E. H. Allen, Jonathan M. Goodman, Steve Gutsell & Paul J. Russell. (2019) Structural Alerts and Random Forest Models in a Consensus Approach for Receptor Binding Molecular Initiating Events. Chemical Research in Toxicology 33:2, pages 388-401.
Crossref
Callum J. Dickson, Camilo Velez-Vega & Jose S. Duca. (2019) Revealing Molecular Determinants of hERG Blocker and Activator Binding. Journal of Chemical Information and Modeling 60:1, pages 192-203.
Crossref
Ulf Neumann, Mike Ufer, Laura H Jacobson, Marie‐Laure Rouzade‐Dominguez, Gunilla Huledal, Carine Kolly, Rainer M Lüönd, Rainer Machauer, Siem J Veenstra, Konstanze Hurth, Heinrich Rueeger, Marina Tintelnot‐Blomley, Matthias Staufenbiel, Derya R Shimshek, Ludovic Perrot, Wilfried Frieauff, Valerie Dubost, Hilmar Schiller, Barbara Vogg, Karen Beltz, Alexandre Avrameas, Sandrine Kretz, Nicole Pezous, Jean‐Michel Rondeau, Nicolau Beckmann, Andreas Hartmann, Stefan Vormfelde, Olivier J David, Bruno Galli, Rita Ramos, Ana Graf & Cristina Lopez Lopez. (2018) The BACE ‐1 inhibitor CNP 520 for prevention trials in Alzheimer's disease . EMBO Molecular Medicine 10:11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.